Original Analysis

The Ethics of Gene Editing

CRISPR technology offers the potential to eradicate genetic diseases, but it also raises profound moral questions about human enhancement.

By Dr. Lisa Mbuyi 1 min read

CRISPR-Cas9 has revolutionized molecular biology, offering a precise, efficient, and relatively inexpensive method for editing DNA. The medical implications are extraordinary, ranging from curing inherited diseases like sickle cell anemia to potentially engineering resistance to certain viruses.

However, the power to alter the human genome comes with immense ethical responsibilities. The possibility of 'designer babies'—where traits like intelligence, height, or eye color could theoretically be selected—blurs the line between therapeutic intervention and mere enhancement. This raises fears of deepening societal inequalities based on genetic advantages.

Moreover, editing the germline (sperm or egg cells) means changes will be passed down to future generations, with unforeseeable long-term consequences. Establishing robust, international ethical guidelines is paramount to ensuring that this powerful technology is used to alleviate suffering without compromising our shared humanity.

Dr. Lisa Mbuyi

Bioethics & Medical Correspondent
M.D., PhD in Bioethics from University of Cape Town

Dr. Lisa Mbuyi covers bioethics, public health policy, and global medical research for Global News Hub. With a background in clinical medicine and ethics, her work focuses on the societal implications of biotechnology and healthcare systems.

View all authors →

Sources & Citations

This analysis is based on primary documents, curated reporting from The Associated Press, Reuters, and verified direct quotes. We adhere to the SPJ Code of Ethics.

Corrections Policy

We are committed to accuracy. If you spot an error in this analysis, please contact us. Read our full corrections policy.

← Browse all analysis & explainers